Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchSelect treatment..Select..
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

 

Characterization and clinical outcomes of outpatients with subacute or chronic post COVID-19 cough: a real-world study

Yao et al., PeerJ, doi:10.7717/peerj.18705
Dec 2024  
  Post
  Facebook
Share
  Source   PDF  
Retrospective 141 outpatients with subacute or chronic post-COVID-19 cough in China, showing ICS/LABA treatment associated with cough relief at 4 weeks.
Yao et al., 11 Dec 2024, China, peer-reviewed, 5 authors, study period August 2023 - February 2024. Contact: guoyunsoochow@163.com, zhoutonghxk@163.com.
This PaperMiscellaneousAll
Characterization and clinical outcomes of outpatients with subacute or chronic post COVID-19 cough: a real-world study
Chun Yao, Dongliang Cheng, Wenhong Yang, Yun Guo, Tong Zhou
PeerJ, doi:10.7717/peerj.18705
Background: Limited research exists on the features and management of post-COVID cough. This real-world study investigates outpatients with subacute or chronic post-COVID cough, aiming to delineate characteristics and regimen responses within the population. Method: We enrolled eligible patients from our outpatient unit between August 2023 and February 2024. Comprehensive clinical data, prescriptions, and patient-reported cough severity were collected during the primary visit and subsequent follow-ups. Result: A total of 141 patients, aged: 42 ± 14 years old, were included, with 70% being female. The median cough duration was 8 weeks (interquartile range 4-12 weeks). Sixty percent presented with a dry cough, while the rest had coughs with phlegm. Over half reported abnormal laryngeal sensations (54%). Twenty-one percent coughed during the day, while 32% coughed constantly, and 48% experienced nocturnal episodes. Compound methoxyphenamine capsules were the most prescribed, but our study found ICS/LABA to be the most effective, followed by compound methoxyphenamine capsules, montelukast, and Chinese patent drugs. Conclusion: Females exhibit a higher prevalence of post-COVID cough, and our study recommends ICS/LABA as the preferred treatment. These findings warrant validation through larger, prospectively designed studies.
ADDITIONAL INFORMATION AND DECLARATIONS Funding This work was supported by the Competitive discipline lift project of the Second Affiliated Hospital of Soochow University (grant number XKTJ-XK202007) and the Science and Technology Program of Suzhou (grant number SKY2021006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grant Disclosures The following grant information was disclosed by the authors: Second Affiliated Hospital of Soochow University: XKTJ-XK202007. Science and Technology Program of Suzhou: SKY2021006. Competing Interests The authors declare that they have no competing interests. Author Contributions . Chun Yao performed the experiments, analyzed the data, prepared figures and/or tables, and approved the final draft. . Dongliang Cheng performed the experiments, analyzed the data, authored or reviewed drafts of the article, and approved the final draft. . Wenhong Yang performed the experiments, analyzed the data, authored or reviewed drafts of the article, and approved the final draft. . Yun Guo conceived and designed the experiments, authored or reviewed drafts of the article, and approved the final draft. . Tong Zhou conceived and designed the experiments, authored or reviewed drafts of the article, and approved the final draft. Human Ethics The following information was supplied relating to ethical approvals (i.e., approving body and any reference numbers): the Second..
References
Branch, Expert consensus on the diagnosis and treatment of SARS-CoV-2-associated cough, Chinese Journal of Tuberculosis and Respiratory Diseases, doi:10.3760/cma.j.cn112147-20230109-00010
Canning, Chang, Bolser, Smith, Mazzone et al., Anatomy and neurophysiology of cough: CHEST guideline and expert panel report, Chest, doi:10.1378/chest.14-1481
Core, R: a language and environment for statistical computing
Fatima, Ismail, Ejaz, Shah, Fatima et al., Association between long COVID and vaccination: a 12-month follow-up study in a low-to middle-income country, PLOS ONE, doi:10.1371/journal.pone.0294780
Gallant, Mercier, Rioux-Perreault, Lemaire-Paquette, Piché, Prevalence of persistent symptoms at least 1 month after SARS-CoV-2 Omicron infection in adults, Journal of the Association of Medical Microbiology and Infectious Disease Canada, doi:10.3138/jammi-2022-0026
García-Vicente, Rodríguez-Valiente, Górriz, Márquez, Martínez-Pérez et al., Chronic cough in post-COVID syndrome: laryngeal electromyography findings in vagus nerve neuropathy, PLOS ONE, doi:10.1371/journal.pone.0283758
Gencer, Caliskaner, Borekci, Gemicioglu, Bronchodilator reversibility testing in long-term cough and dyspnea after COVID-19 viral infection: a trigger for asthma?, Journal of Asthma, doi:10.1080/02770903.2022.2139719
Gentilotti, Górska, Tami, Gusinow, Mirandola et al., Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort, EClinicalMedicine, doi:10.1016/j.eclinm.2023.102107
Herman, Wong, Viwattanakulvanid, Vaccination status, favipiravir, and micronutrient supplementation roles in post-COVID symptoms: a longitudinal study, PLOS ONE, doi:10.1371/journal.pone.0271385
Jain, Nabi, Aggarwal, Alam, Chandra et al., Long-term health consequences of COVID-19 in survivors hospitalised at a tertiary care hospital and their correlation with acute COVID-19 severity and associated risk factors, Journal of Clinical Nursing, doi:10.1111/jocn.16652
Kanemitsu, Fukumitsu, Niimi, Relevant factors associated with the development of chronic cough after recovery from COVID-19, Respiratory Investigation, doi:10.1016/j.resinv.2024.01.003
Mahmoud, Radwan, Alkattan, Hassanien, Elkajam et al., Post-COVID-19 syndrome: nature of symptoms and associated factors, Journal of Public Health-Heidelberg, doi:10.1007/s10389-022-01802-3
Mazzone, Satia, Mcgarvey, Song, Chung, Chronic cough and cough hypersensitivity: from mechanistic insights to novel antitussives, Lancet Respiratory Medicine, doi:10.1016/S2213-2600(22)00404-0
Mohamed, Johansson, Jonsson, Schiöth, Dissecting the molecular mechanisms surrounding post-COVID-19 syndrome and neurological features, International Journal of Molecular Sciences, doi:10.3390/ijms23084275
Morice, Millqvist, Bieksiene, Birring, Dicpinigaitis et al., ERS guidelines on the diagnosis and treatment of chronic cough in adults and children, European Respiratory Journal, doi:10.1183/13993003.01136-2019
Morioka, Tsuzuki, Maruki, Terada, Miyazato et al., Epidemiology of post-COVID conditions beyond 1 year: a cross-sectional study, Public Health, doi:10.1016/j.puhe.2023.01.008
Pahar, Klopper, Warren, Niesler, COVID-19 cough classification using machine learning and global smartphone recordings, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104572
Pahar, Klopper, Warren, Niesler, COVID-19 detection in cough, breath and speech using deep transfer learning and bottleneck features, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.105153
Rochmawati, Iskandar, Persistent symptoms among post-COVID-19 survivors: a systematic review and meta-analysis, Journal of Clinical Nursing, doi:10.1111/jocn.16471
Salve, Daniel, Kumar, Kumar, Misra, Prevalence and determinants of long COVID among patients attending the outpatient department of a subdistrict hospital in Haryana, Cureus Journal of Medical Science, doi:10.7759/cureus.46007
Shang, Chang, Yang, Shi, Hu et al., Analysis of influencing factors on long COVID in COVID-19 patients infected with omicron variant three months after discharge: a cross-sectional study, BMC Infectious Diseases, doi:10.1186/s12879-023-08947-w
Song, Hui, Hull, Birring, Mcgarvey et al., Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses, Lancet Respiratory Medicine, doi:10.1016/S2213-2600(21)00125-9
Von Elm, Altman, Egger, Pocock, Gøtzsche et al., The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies, Annals of Internal Medicine, doi:10.7326/0003-4819-147-8-200710160-00010
Wan, Sundram, Abdul, Dashuki, Ahad et al., Long COVID active case detection initiative among COVID-19 patients in Port Dickson, Malaysia: a retrospective study on the positive outcomes, the proportion of patients with long COVID and its associated factors, PeerJ, doi:10.7717/peerj.14742
Wang, Birring, Taylor, Fry, Hay et al., Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial, Lancet Respiratory Medicine, doi:10.1016/S2213-2600(13)70245-5
Zhou, Qu, Zhu, Deng, Wan et al., A multicenter study to evaluate the efficacy and safety of compound methoxyphenamine in the treatment of postinfectious cough, Chinese Journal of Asthma, doi:10.3969/j.issn.1674-3911.2011.06.005
DOI record: { "DOI": "10.7717/peerj.18705", "ISSN": [ "2167-8359" ], "URL": "http://dx.doi.org/10.7717/peerj.18705", "abstract": "<jats:sec>\n<jats:title>Background</jats:title>\n<jats:p>Limited research exists on the features and management of post-COVID cough. This real-world study investigates outpatients with subacute or chronic post-COVID cough, aiming to delineate characteristics and regimen responses within the population.</jats:p>\n</jats:sec>\n<jats:sec>\n<jats:title>Method</jats:title>\n<jats:p>We enrolled eligible patients from our outpatient unit between August 2023 and February 2024. Comprehensive clinical data, prescriptions, and patient-reported cough severity were collected during the primary visit and subsequent follow-ups.</jats:p>\n</jats:sec>\n<jats:sec>\n<jats:title>Result</jats:title>\n<jats:p>A total of 141 patients, aged: 42 ± 14 years old, were included, with 70% being female. The median cough duration was 8 weeks (interquartile range 4–12 weeks). Sixty percent presented with a dry cough, while the rest had coughs with phlegm. Over half reported abnormal laryngeal sensations (54%). Twenty-one percent coughed during the day, while 32% coughed constantly, and 48% experienced nocturnal episodes. Compound methoxyphenamine capsules were the most prescribed, but our study found ICS/LABA to be the most effective, followed by compound methoxyphenamine capsules, montelukast, and Chinese patent drugs.</jats:p>\n</jats:sec>\n<jats:sec>\n<jats:title>Conclusion</jats:title>\n<jats:p>Females exhibit a higher prevalence of post-COVID cough, and our study recommends ICS/LABA as the preferred treatment. These findings warrant validation through larger, prospectively designed studies.</jats:p>\n</jats:sec>", "alternative-id": [ "10.7717/peerj.18705" ], "article-number": "e18705", "author": [ { "affiliation": [], "family": "Yao", "given": "Chun", "sequence": "first" }, { "affiliation": [], "family": "Cheng", "given": "Dongliang", "sequence": "additional" }, { "affiliation": [], "family": "Yang", "given": "Wenhong", "sequence": "additional" }, { "affiliation": [], "family": "Guo", "given": "Yun", "sequence": "additional" }, { "affiliation": [], "family": "Zhou", "given": "Tong", "sequence": "additional" } ], "container-title": "PeerJ", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2024, 12, 11 ] ], "date-time": "2024-12-11T09:05:33Z", "timestamp": 1733907933000 }, "deposited": { "date-parts": [ [ 2024, 12, 11 ] ], "date-time": "2024-12-11T09:05:46Z", "timestamp": 1733907946000 }, "funder": [ { "DOI": "10.13039/501100014358", "award": [ "XKTJ-XK202007" ], "doi-asserted-by": "crossref", "id": [ { "asserted-by": "crossref", "id": "10.13039/501100014358", "id-type": "DOI" } ], "name": "Second Affiliated Hospital of Soochow University" }, { "DOI": "10.13039/501100018556", "award": [ "SKY2021006" ], "doi-asserted-by": "crossref", "id": [ { "asserted-by": "crossref", "id": "10.13039/501100018556", "id-type": "DOI" } ], "name": "Science and Technology Program of Suzhou" } ], "indexed": { "date-parts": [ [ 2024, 12, 12 ] ], "date-time": "2024-12-12T05:29:04Z", "timestamp": 1733981344700, "version": "3.30.2" }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2024, 12, 11 ] ] }, "language": "en", "license": [ { "URL": "https://creativecommons.org/licenses/by/4.0/", "content-version": "unspecified", "delay-in-days": 0, "start": { "date-parts": [ [ 2024, 12, 11 ] ], "date-time": "2024-12-11T00:00:00Z", "timestamp": 1733875200000 } } ], "link": [ { "URL": "https://peerj.com/articles/18705.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://peerj.com/articles/18705.xml", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://peerj.com/articles/18705.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://peerj.com/articles/18705.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "4443", "original-title": [], "page": "e18705", "prefix": "10.7717", "published": { "date-parts": [ [ 2024, 12, 11 ] ] }, "published-online": { "date-parts": [ [ 2024, 12, 11 ] ] }, "publisher": "PeerJ", "reference": [ { "DOI": "10.3760/cma.j.cn112147-20230109-00010", "article-title": "Expert consensus on the diagnosis and treatment of SARS-CoV-2-associated cough", "author": "Branch", "doi-asserted-by": "publisher", "first-page": "217", "journal-title": "Chinese Journal of Tuberculosis and Respiratory Diseases", "key": "10.7717/peerj.18705/ref-1", "volume": "46", "year": "2023" }, { "DOI": "10.1378/chest.14-1481", "article-title": "Anatomy and neurophysiology of cough: CHEST guideline and expert panel report", "author": "Canning", "doi-asserted-by": "publisher", "first-page": "1633", "issue": "6", "journal-title": "Chest", "key": "10.7717/peerj.18705/ref-2", "volume": "146", "year": "2014" }, { "DOI": "10.1371/journal.pone.0294780", "article-title": "Association between long COVID and vaccination: a 12-month follow-up study in a low- to middle-income country", "author": "Fatima", "doi-asserted-by": "publisher", "first-page": "e294780", "issue": "11", "journal-title": "PLOS ONE", "key": "10.7717/peerj.18705/ref-3", "volume": "18", "year": "2023" }, { "DOI": "10.3138/jammi-2022-0026", "article-title": "Prevalence of persistent symptoms at least 1 month after SARS-CoV-2 Omicron infection in adults", "author": "Gallant", "doi-asserted-by": "publisher", "first-page": "57", "issue": "1", "journal-title": "Journal of the Association of Medical Microbiology and Infectious Disease Canada", "key": "10.7717/peerj.18705/ref-4", "volume": "8", "year": "2023" }, { "DOI": "10.1371/journal.pone.0283758", "article-title": "Chronic cough in post-COVID syndrome: laryngeal electromyography findings in vagus nerve neuropathy", "author": "García-Vicente", "doi-asserted-by": "publisher", "first-page": "e283758", "issue": "3", "journal-title": "PLOS ONE", "key": "10.7717/peerj.18705/ref-5", "volume": "18", "year": "2023" }, { "DOI": "10.1080/02770903.2022.2139719", "article-title": "Bronchodilator reversibility testing in long-term cough and dyspnea after COVID-19 viral infection: a trigger for asthma?", "author": "Gencer", "doi-asserted-by": "publisher", "first-page": "1221", "issue": "6", "journal-title": "Journal of Asthma", "key": "10.7717/peerj.18705/ref-6", "volume": "60", "year": "2023" }, { "DOI": "10.1016/j.eclinm.2023.102107", "article-title": "Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort", "author": "Gentilotti", "doi-asserted-by": "publisher", "first-page": "102107", "issue": "163", "journal-title": "EClinicalMedicine", "key": "10.7717/peerj.18705/ref-7", "volume": "62", "year": "2023" }, { "article-title": "Global strategy for asthma management and prevention, 2023", "author": "Global Initiative for Asthma", "key": "10.7717/peerj.18705/ref-8", "year": "2023" }, { "DOI": "10.1371/journal.pone.0271385", "article-title": "Vaccination status, favipiravir, and micronutrient supplementation roles in post-COVID symptoms: a longitudinal study", "author": "Herman", "doi-asserted-by": "publisher", "first-page": "e271385", "issue": "7", "journal-title": "PLOS ONE", "key": "10.7717/peerj.18705/ref-9", "volume": "17", "year": "2022" }, { "DOI": "10.1111/jocn.16652", "article-title": "Long-term health consequences of COVID-19 in survivors hospitalised at a tertiary care hospital and their correlation with acute COVID-19 severity and associated risk factors", "author": "Jain", "doi-asserted-by": "publisher", "first-page": "115", "issue": "1", "journal-title": "Journal of Clinical Nursing", "key": "10.7717/peerj.18705/ref-10", "volume": "33", "year": "2024" }, { "DOI": "10.1016/j.resinv.2024.01.003", "article-title": "Relevant factors associated with the development of chronic cough after recovery from COVID-19", "author": "Kanemitsu", "doi-asserted-by": "publisher", "first-page": "269", "issue": "2", "journal-title": "Respiratory Investigation", "key": "10.7717/peerj.18705/ref-11", "volume": "62", "year": "2024" }, { "DOI": "10.1007/s10389-022-01802-3", "article-title": "Post-COVID-19 syndrome: nature of symptoms and associated factors", "author": "Mahmoud", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "Journal of Public Health-Heidelberg", "key": "10.7717/peerj.18705/ref-12", "volume": "3", "year": "2023" }, { "DOI": "10.1016/S2213-2600(22)00404-0", "article-title": "Chronic cough and cough hypersensitivity: from mechanistic insights to novel antitussives", "author": "Mazzone", "doi-asserted-by": "publisher", "first-page": "1113", "issue": "12", "journal-title": "Lancet Respiratory Medicine", "key": "10.7717/peerj.18705/ref-13", "volume": "10", "year": "2022" }, { "DOI": "10.3390/ijms23084275", "article-title": "Dissecting the molecular mechanisms surrounding post-COVID-19 syndrome and neurological features", "author": "Mohamed", "doi-asserted-by": "publisher", "first-page": "4275", "issue": "8", "journal-title": "International Journal of Molecular Sciences", "key": "10.7717/peerj.18705/ref-14", "volume": "23", "year": "2022" }, { "DOI": "10.1183/13993003.01136-2019", "article-title": "ERS guidelines on the diagnosis and treatment of chronic cough in adults and children", "author": "Morice", "doi-asserted-by": "publisher", "first-page": "1901136", "issue": "1", "journal-title": "European Respiratory Journal", "key": "10.7717/peerj.18705/ref-15", "volume": "55", "year": "2020" }, { "DOI": "10.1016/j.puhe.2023.01.008", "article-title": "Epidemiology of post-COVID conditions beyond 1 year: a cross-sectional study", "author": "Morioka", "doi-asserted-by": "publisher", "first-page": "39", "journal-title": "Public Health", "key": "10.7717/peerj.18705/ref-16", "volume": "216", "year": "2023" }, { "DOI": "10.1016/j.compbiomed.2021.104572", "article-title": "COVID-19 cough classification using machine learning and global smartphone recordings", "author": "Pahar", "doi-asserted-by": "publisher", "first-page": "104572", "journal-title": "Computers in Biology and Medicine", "key": "10.7717/peerj.18705/ref-17", "volume": "135", "year": "2021" }, { "DOI": "10.1016/j.compbiomed.2021.105153", "article-title": "COVID-19 detection in cough, breath and speech using deep transfer learning and bottleneck features", "author": "Pahar", "doi-asserted-by": "publisher", "first-page": "105153", "journal-title": "Computers in Biology and Medicine", "key": "10.7717/peerj.18705/ref-18", "volume": "141", "year": "2022" }, { "author": "R Core Team", "key": "10.7717/peerj.18705/ref-19", "volume-title": "R: a language and environment for statistical computing", "year": "2023" }, { "DOI": "10.1111/jocn.16471", "article-title": "Persistent symptoms among post-COVID-19 survivors: a systematic review and meta-analysis", "author": "Rochmawati", "doi-asserted-by": "publisher", "first-page": "29", "issue": "1", "journal-title": "Journal of Clinical Nursing", "key": "10.7717/peerj.18705/ref-20", "volume": "33", "year": "2024" }, { "DOI": "10.7759/cureus.46007", "article-title": "Prevalence and determinants of long COVID among patients attending the outpatient department of a subdistrict hospital in Haryana", "author": "Salve", "doi-asserted-by": "publisher", "first-page": "e46007", "journal-title": "Cureus Journal of Medical Science", "key": "10.7717/peerj.18705/ref-21", "volume": "15", "year": "2023" }, { "DOI": "10.1186/s12879-023-08947-w", "article-title": "Analysis of influencing factors on long COVID in COVID-19 patients infected with omicron variant three months after discharge: a cross-sectional study", "author": "Shang", "doi-asserted-by": "publisher", "first-page": "36", "journal-title": "BMC Infectious Diseases", "key": "10.7717/peerj.18705/ref-22", "volume": "24", "year": "2024" }, { "DOI": "10.1016/S2213-2600(21)00125-9", "article-title": "Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses", "author": "Song", "doi-asserted-by": "publisher", "first-page": "533", "issue": "5", "journal-title": "Lancet Respiratory Medicine", "key": "10.7717/peerj.18705/ref-23", "volume": "9", "year": "2021" }, { "DOI": "10.7326/0003-4819-147-8-200710160-00010", "article-title": "The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies", "author": "von Elm", "doi-asserted-by": "publisher", "first-page": "573", "issue": "8", "journal-title": "Annals of Internal Medicine", "key": "10.7717/peerj.18705/ref-24", "volume": "147", "year": "2007" }, { "DOI": "10.7717/peerj.14742", "article-title": "Long COVID active case detection initiative among COVID-19 patients in Port Dickson, Malaysia: a retrospective study on the positive outcomes, the proportion of patients with long COVID and its associated factors", "author": "Wan", "doi-asserted-by": "publisher", "first-page": "e14742", "issue": "4", "journal-title": "PeerJ", "key": "10.7717/peerj.18705/ref-25", "volume": "11", "year": "2023" }, { "DOI": "10.1016/S2213-2600(13)70245-5", "article-title": "Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial", "author": "Wang", "doi-asserted-by": "publisher", "first-page": "35", "issue": "1", "journal-title": "Lancet Respiratory Medicine", "key": "10.7717/peerj.18705/ref-26", "volume": "2", "year": "2014" }, { "article-title": "Coronavirus disease (COVID-19) pandemic", "author": "World Health Organization (WHO)", "key": "10.7717/peerj.18705/ref-27", "year": "2024a" }, { "article-title": "COVID-19 dashboard", "author": "World Health Organization (WHO)", "key": "10.7717/peerj.18705/ref-28", "year": "2024b" }, { "DOI": "10.3969/j.issn.1674-3911.2011.06.005", "article-title": "A multicenter study to evaluate the efficacy and safety of compound methoxyphenamine in the treatment of postinfectious cough", "author": "Zhou", "doi-asserted-by": "publisher", "first-page": "407", "issue": "6", "journal-title": "Chinese Journal of Asthma", "key": "10.7717/peerj.18705/ref-29", "volume": "5", "year": "2011" } ], "reference-count": 29, "references-count": 29, "relation": {}, "resource": { "primary": { "URL": "https://peerj.com/articles/18705" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Characterization and clinical outcomes of outpatients with subacute or chronic post COVID-19 cough: a real-world study", "type": "journal-article", "volume": "12" }
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit